FDA Approval of Dupixent for COPD by September 27, 2024? | Binary | | | 7 months ago | |
Will Dupixent sales grow in Q4 2024? | Binary | | | 7 months ago | |
Will Dupixent receive additional approvals for new indications by end of 2024? | Binary | | | 7 months ago | |
Market Share of Dupixent in COPD Treatments in Europe by end of 2024 | Categorical | | | 7 months ago | |
Sanofi Stock Price Change Within One Week After FDA Decision on Dupixent | Categorical | | | 7 months ago | |
Dupixent's Ranking Among Top-Selling Drugs Worldwide in 2024 | Categorical | | | 7 months ago | |
Will the FDA approve Soleno's NDA for DCCR for Prader-Willi Syndrome by December 27, 2024? | Binary | | | 4 months ago | |
Will the FDA approve SpringWorks' NDA for Mirdametinib for NF1-PN by the end of 2024? | Binary | | | 4 months ago | |
Will SpringWorks Therapeutics' stock increase by at least 5% within one week after FDA decision on Mirdametinib? | Binary | | | 4 months ago | |
What will be the outcome of the FDA AdComm meeting on Soleno's NDA for DCCR by December 27, 2024? | Categorical | | | 4 months ago | |
How will Soleno Therapeutics' stock react within one week after FDA decision on DCCR? | Categorical | | | 4 months ago | |
How will SpringWorks Therapeutics' stock react within one week after FDA decision on Mirdametinib? | Categorical | | | 4 months ago | |
